Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) - Total Assets

Latest as of September 2025: CN¥2.98 Billion CNY ≈ $436.60 Million USD

Based on the latest financial reports, Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) holds total assets worth CN¥2.98 Billion CNY (≈ $436.60 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) net assets for net asset value and shareholders' equity analysis.

Jilin Jian Yisheng Pharmaceutical Co Ltd - Total Assets Trend (2006–2024)

This chart illustrates how Jilin Jian Yisheng Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data.

Jilin Jian Yisheng Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Jilin Jian Yisheng Pharmaceutical Co Ltd's total assets of CN¥2.98 Billion consist of 80.0% current assets and 20.0% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	2.4%
Accounts Receivable	CN¥214.08 Million	7.2%
Inventory	CN¥1.63 Billion	54.8%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥111.35 Million	3.8%
Goodwill	CN¥1.91 Million	0.1%

Asset Composition Trend (2006–2024)

This chart illustrates how Jilin Jian Yisheng Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Jilin Jian Yisheng Pharmaceutical Co Ltd's current assets represent 80.0% of total assets in 2024, an increase from 70.6% in 2006.
Cash Position: Cash and equivalents constituted 2.4% of total assets in 2024, down from 8.6% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 2.0% in 2006.
Asset Diversification: The largest asset category is inventory at 54.8% of total assets.

Jilin Jian Yisheng Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Jilin Jian Yisheng Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$7.59 Billion
Summit Therapeutics PLC NASDAQ:SMMT	USA	$261.73 Million
Argen-X F:1AE	Germany	€7.18 Billion
Metsera, Inc. Common Stock NASDAQ:MTSR	USA	$639.66 Million
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	China	CN¥3.06 Billion
R&G PharmaStudies Co. Ltd. A SHE:301333	China	CN¥2.31 Billion
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	China	CN¥819.45 Million
Innovita Biological Technology Co. Ltd. A SHG:688253	China	CN¥2.16 Billion

Jilin Jian Yisheng Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	5.82	5.74	3.87
Quick Ratio	1.95	1.85	1.06
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥2.00 Billion	CN¥1.98 Billion	CN¥1.65 Billion

Jilin Jian Yisheng Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Jilin Jian Yisheng Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.24
Latest Market Cap to Assets Ratio	0.14
Asset Growth Rate (YoY)	-2.5%
Total Assets	CN¥2.97 Billion
Market Capitalization	$403.41 Million USD

Valuation Analysis

Below Book Valuation: The market values Jilin Jian Yisheng Pharmaceutical Co Ltd's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Jilin Jian Yisheng Pharmaceutical Co Ltd's assets decreased by 2.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual total assets of Jilin Jian Yisheng Pharmaceutical Co Ltd from 2006 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥2.97 Billion ≈ $434.70 Million	-2.50%
2023-12-31	CN¥3.05 Billion ≈ $445.83 Million	+2.70%
2022-12-31	CN¥2.97 Billion ≈ $434.11 Million	+3.57%
2021-12-31	CN¥2.86 Billion ≈ $419.15 Million	+2.44%
2020-12-31	CN¥2.80 Billion ≈ $409.16 Million	+12.00%
2019-12-31	CN¥2.50 Billion ≈ $365.32 Million	-2.22%
2018-12-31	CN¥2.55 Billion ≈ $373.60 Million	-3.78%
2017-12-31	CN¥2.65 Billion ≈ $388.29 Million	-0.65%
2016-12-31	CN¥2.67 Billion ≈ $390.81 Million	+1.40%
2015-12-31	CN¥2.63 Billion ≈ $385.40 Million	+5.76%
2014-12-31	CN¥2.49 Billion ≈ $364.42 Million	+31.72%
2013-12-31	CN¥1.89 Billion ≈ $276.66 Million	+13.75%
2012-12-31	CN¥1.66 Billion ≈ $243.23 Million	+5.29%
2011-12-31	CN¥1.58 Billion ≈ $231.00 Million	+206.49%
2010-12-31	CN¥515.06 Million ≈ $75.37 Million	+20.44%
2009-12-31	CN¥427.66 Million ≈ $62.58 Million	+23.13%
2008-12-31	CN¥347.32 Million ≈ $50.82 Million	+1.65%
2007-12-31	CN¥341.67 Million ≈ $50.00 Million	+1.07%
2006-12-31	CN¥338.04 Million ≈ $49.47 Million	--

About Jilin Jian Yisheng Pharmaceutical Co Ltd

SHE:002566 China Biotechnology

Market Cap

$403.41 Million

CN¥2.76 Billion CNY

Market Cap Rank

#13642 Global

#4309 in China

Share Price

CN¥8.33

Change (1 day)

+0.48%

52-Week Range

CN¥7.07 - CN¥9.05

All Time High

CN¥19.38